EUVIMEDEUVIMED entdecken
Crossref

A Bifunctional Sulfide Donor Approach for Ischemic Stroke: Leveraging Butylphthalide as a Carrier for Sulfide Prodrug

Wen Peng, Jianru Liu, Zhen Li, Yuanan Wang, Yangqian Sun, Yanzhao Chen, David J Lefer, Weiwei Guo iD, Yueqin Zheng iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c02454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Wen Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Center of Drug Discovery, China Pharmaceutical University, Nanjing 211198, P. R. China. Hauptthemen laut MEDLINE: Benzofurans, Prodrugs, Sulfides, Ischemic Stroke. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: State Key Laboratory of Natural Medicines, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The physiological and pharmacological benefits of hydrogen sulfide (H2S) are well established, and various H2S and persulfide donors have been developed. However, few studies have examined the in vivo pharmacokinetics of sulfur donors, as most activity and metabolism tests are conducted in vitro, limiting insights into their clinical applications. This study utilized butylphthalide (NBP), an approved drug for ischemic stroke, by integrating H2S and persulfide moieties directly into NBP's carbonyl groups. We systematically compared drug metabolism in vitro and in vivo and evaluated donor efficacy in ischemia-reperfusion models. Results revealed notable in vitro/in vivo metabolic differences, with thioacid-containing donors showing promising therapeutic effects in cerebral ischemia, reducing infarct size, oxidative stress, and neuronal apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzofuransProdrugsSulfidesIschemic StrokeHydrogen SulfideAnimalsMaleMiceApoptosisHumansNeuroprotective AgentsMice, Inbred C57BLOxidative Stress

Substanzen

BenzofuransProdrugs3-n-butylphthalideSulfidesHydrogen SulfideNeuroprotective Agents

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Center of Drug Discovery, China Pharmaceutical University, Nanjing 211198, P. R. China.
  • Department of Cardiac Surgery Smidt Heart Institute, Cedars-Sinai Medical Center, 127 S, Los Angeles, California 90048, United States.
  • School of Science, China Pharmaceutical University, Nanjing 211198, P. R. China.

ORCID-Profile: Weiwei Guo, Yueqin Zheng

Förderung

  • State Key Laboratory of Natural Medicines
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Peng, W., Liu, J., Li, Z., Wang, Y., Sun, Y., Chen, Y., Lefer, D. J., Guo, W., & Zheng, Y. (2024). A Bifunctional Sulfide Donor Approach for Ischemic Stroke: Leveraging Butylphthalide as a Carrier for Sulfide Prodrug. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02454

Vancouver

Peng W, Liu J, Li Z, Wang Y, Sun Y, Chen Y, et al. A Bifunctional Sulfide Donor Approach for Ischemic Stroke: Leveraging Butylphthalide as a Carrier for Sulfide Prodrug. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c02454

BibTeX
@article{Peng2024,
  author = {Peng, Wen and Liu, Jianru and Li, Zhen and Wang, Yuanan and Sun, Yangqian and Chen, Yanzhao and Lefer, David J and Guo, Weiwei and Zheng, Yueqin},
  title = {A Bifunctional Sulfide Donor Approach for Ischemic Stroke: Leveraging Butylphthalide as a Carrier for Sulfide Prodrug},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c02454}
}
Kostenlos starten →